Raffles Medical Group Ltd

DB:02M1 Stock Report

Market Cap: €1.2b

Raffles Medical Group Future Growth

Future criteria checks 1/6

Raffles Medical Group is forecast to grow earnings and revenue by 12.6% and 4% per annum respectively. EPS is expected to grow by 10.9% per annum. Return on equity is forecast to be 7.3% in 3 years.

Key information

12.6%

Earnings growth rate

10.9%

EPS growth rate

Healthcare earnings growth20.6%
Revenue growth rate4.0%
Future return on equity7.3%
Analyst coverage

Good

Last updated01 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:02M1 - Analysts future estimates and past financials data (SGD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026821831061235
12/31/2025785781001238
12/31/202474169-8988
6/30/2024703617297N/A
3/31/202470676120143N/A
12/31/202370890167189N/A
9/30/2023747117166189N/A
6/30/2023786144165188N/A
3/31/2023805143168192N/A
12/31/2022825143171196N/A
9/30/2022808124179204N/A
6/30/2022791104188212N/A
3/31/202275894148186N/A
12/31/202172584107160N/A
9/30/202169886108171N/A
6/30/202167188109181N/A
3/31/20216197791157N/A
12/31/20205686673133N/A
9/30/20205416042121N/A
6/30/20205085023105N/A
3/31/20205145521107N/A
12/31/20195226013111N/A
9/30/2019514631693N/A
6/30/2019504662892N/A
3/31/2019497693589N/A
12/31/2018489716294N/A
9/30/2018484716388N/A
6/30/2018483715781N/A
3/31/201848371N/A88N/A
12/31/201747871N/A83N/A
9/30/201747370N/A81N/A
6/30/201747370N/A65N/A
3/31/201747270N/A63N/A
12/31/201647470N/A79N/A
9/30/201647071N/A83N/A
6/30/201645271N/A92N/A
3/31/201643270N/A91N/A
12/31/201541169N/A73N/A
9/30/201539669N/A86N/A
6/30/201538968N/A79N/A
3/31/201538268N/A94N/A
12/31/201437568N/A93N/A
9/30/201436389N/A66N/A
6/30/201435387N/A83N/A
3/31/201434786N/A71N/A
12/31/201334185N/A71N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 02M1's forecast earnings growth (12.6% per year) is above the savings rate (0.8%).

Earnings vs Market: 02M1's earnings (12.6% per year) are forecast to grow slower than the German market (20.2% per year).

High Growth Earnings: 02M1's earnings are forecast to grow, but not significantly.

Revenue vs Market: 02M1's revenue (4% per year) is forecast to grow slower than the German market (5.4% per year).

High Growth Revenue: 02M1's revenue (4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 02M1's Return on Equity is forecast to be low in 3 years time (7.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y